Indiana American Water releases 2024 Water Quality Reports
FARMERSBURG, Ind. (WTWO/WAWV)— Indiana American Water has released its most recent Water Quality Reports for a part of the Wabash Valley.
Residents in western Indiana can now check their Water Quality Reports depending on their area. You can check based on the location breakdown below:
Terre Haute– this section covers Terre Haute, Marion Heights, Lost Creek, Honey Creek, Otter Creek, Sugar Creek, Riley and Linton Townships.
Farmersburg– this section covers Farmersburg and surrounding Curry Township, and a small portion of the southernmost part of Linton Township in Vigo County.
Sullivan– this section covers the City of Sullivan, the Town of New Lebanon, and parts of the Surrounding Gill and Hamilton townships.
Merom– covering the town of Merom
Mecca– covering the town of Mecca
The release from Indiana American Water states that customers across Indiana's water met or surpassed all state and federal water quality standards for all regulated substances. The reports above detail the quality of the water provided to their customers from data collection over 2024. The reports also contain results of tests conducted on certain unregulated compounds in areas where they were present.
'At Indiana American Water, our mission is to provide safe, clean, reliable, and affordable water to our customers,' said Christina Gosnell, Senior Manager of Water Quality and Environmental Compliance, Indiana American Water. 'Our annual reports inform customers about their water quality and include details about their water, such as the specific water source and information on the importance of protecting our drinking water sources.'
You can access specific reports by visiting the water quality tab on their website and searching by zip code. Customers can also request a physical copy of the report by calling 1-800-492-8373.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Mobile mayoral candidate Spiro Cheriogotis takes a sizeable lead in campaign contributions
MOBILE, Ala. (WKRG) — Spiro Cheriogotis extended his financial advantage over Mobile's five other mayoral candidates last month, according to campaign finance filings with the Alabama Secretary of State. Orange Beach Billfish Classic ends with record purse Cheriogotis, a former Mobile County District Judge, received cash contributions of $231,000 in May, three times more than the next candidate was able to raise, and more than the other five candidates combined. County Commissioner Connie Hudson received cash contributions of $75,200. Former Mobile Police Chief Paul Prine raised $40,900. State Representative Barbara Drummond received $29,300 in cash donations. Former City Councilman Jermaine Burrell raised $22,300. Former Police Chief Lawrence Battiste received $1,750 in cash donations. With the election 11 weeks out, Cheriogotis has almost more cash on hand than his five opponents combined. His campaign balance at the end of May was $676,400. Hudson had $397,600 on hand, Drummond $129,200, Burrell $75,700, Prine $69,100 and Battiste $5,700. Hudson carried over $158,000 from her last campaign for County Commissioner. Drummond brought $30,000 from her State Representative campaign balance. Baldwin County's first Safe Haven baby box blessed in Daphne Cheriogotis has been endorsed by outgoing Mayor Sandy Stimpson who is not running for a fourth four-year term. This is the first time in 20 years that a Mobile mayoral election has not featured an incumbent. The election is Aug. 26. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
35 minutes ago
- Yahoo
GeoVax to Participate in BIO International Convention 2025
ATLANTA, GA - June 12, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies, today announced that company representatives will attend the 2025 BIO International Convention being held June 16-19, 2025 at the Boston Convention and Exhibition Center in Boston, Massachusetts. The BIO International Convention is the world's largest gathering of the biotechnology industry, attracting thousands of biotechnology and pharmaceutical executives from around the globe. The event provides an ideal venue for companies to engage with potential partners, investors, and policymakers. During the convention, GeoVax will participate in business development and partnering meetings to discuss its expanding pipeline of infectious disease and cancer immunotherapies, including GEO-MVA, a Modified Vaccinia Ankara (MVA)-based vaccine targeting Mpox and smallpox; GEO-CM04S1, a multi-antigen COVID-19 vaccine candidate; and Gedeptin(R), a gene-directed enzyme prodrug therapy for the treatment of solid tumors. GeoVax's participation at BIO 2025 supports its broader business development strategy, including ongoing efforts to establish strategic partnerships, expand manufacturing capabilities, and align with public and private sector priorities in pandemic preparedness, oncology, and biodefense. About GeoVax GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines against infectious diseases and therapies for solid tumor cancers. The Company's lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin(R), having recently completed a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. The Company is also developing GEO-MVA, a vaccine targeting Mpox and smallpox. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. For more information about the current status of our clinical trials and other updates, visit our website: Company Contact:info@ Investor Relationsgeovax@ Contact: Media Contact:Jessica Starmanmedia@ View the original release on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
XTI Accelerates xVTOL Development by Collaboration with the U.S. Department of Energy's Oak Ridge National Laboratory Frontier Supercomputer
ENGLEWOOD, Colo., June 12, 2025 /PRNewswire/ -- XTI Aerospace, Inc. (Nasdaq: XTIA) ("XTI"), a pioneer in xVTOL and powered-lift aircraft solutions, today reported that it has successfully accelerated performance analysis of the aerodynamics design of the TriFan 600 xVTOL aircraft, having completed more than 1,500 complex computational fluid dynamics (CFD) calculations. The CFD analysis performed using the Frontier supercomputer – capable of executing over a quintillion calculations per second – positions the XTI engineering team to optimize performance and safety as it prepares to fly subscale versions of the TriFan 600 xVTOL. By digitally simulating the TriFan 600 xVTOL in various configurations, attitudes, speeds, and other unique mission profiles, XTI has been able to realize anticipated improvements in aerodynamics as it prepares for formal wind tunnel confirmation tests, which will form part of the Federal Aviation Adminstration (FAA) certification process for the TriFan 600 xVTOL. Scott Pomeroy, Chairman and CEO of XTI Aerospace, commented, "As we pioneer the Vertical Economy, our collaboration with Oak Ridge gives XTI a critical advantage: compressing and accelerating the work of our engineering teams while de-risking key aspects of our TriFan 600 xVTOL design." About XTI Aerospace, Inc. XTI Aerospace ( (Nasdaq: XTIA) is the parent company of XTI Aircraft Company, an aviation business based near Denver, Colorado, currently developing the TriFan 600, a fixed-wing business aircraft designed to have the vertical takeoff and landing (VTOL) capability of a helicopter, maximum cruising speeds of 311 mph and a range of 985 miles, creating an entirely new category – the xVTOL. Additionally, the Inpixon ( business unit of XTI Aerospace is a leader in real-time location systems (RTLS) technology with customers around the world who use the Company's location intelligence solutions in factories and other industrial facilities to help optimize operations, increase productivity, and enhance safety. For more information about XTI, please visit and follow XTI on LinkedIn, Instagram, X, and YouTube. Cautionary Statement Regarding Forward-Looking Statements This press release contains certain "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of the Exchange Act. All statements other than statements of historical fact contained in this press release, including without limitation, statements about the expected benefits of future collaborations with Oak Ridge National Laboratory, the products under development by XTI, the advantages of XTI's technology, and XTI's customers, plans and strategies are forward-looking statements. Some of these forward-looking statements can be identified by the use of forward-looking words, including "believe," "continue," "could," "would," "will," "estimate," "expect," "intend," "plan," "target," "projects," or the negatives of these terms or variations of them or similar expressions. All forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. All forward-looking statements are based upon estimates, forecasts, and assumptions that, while considered reasonable by XTI Aerospace and its management, are inherently uncertain, and many factors may cause the actual results to differ materially from current expectations, which include, but are not limited to, XTI's ability to meet its development and commercialization schedule with respect to the TriFan 600, and the risk that XTI and its current and future collaborators may be unable to successfully develop and market XTI's aircraft or may experience significant delays in doing so. XTI undertakes no obligation to revise any forward-looking statements in order to reflect events or circumstances that might subsequently arise. Readers are urged to carefully review and consider the risk factors discussed from time to time in XTI's filings with the SEC, including those factors discussed under the caption "Risk Factors" in its most recent annual report on Form 10-K, filed with the SEC on April 15, 2025, and in subsequent reports filed with or furnished to the SEC. Contacts General inquiries:Email: contact@ Web: Investor Relations:Dave Gentry, CEORedChip Companies, 1-407-644-4256Email: XTIA@ View original content to download multimedia: SOURCE XTI Aerospace, Inc.
